Which immune markers actually change with poor sleep?
The best-replicated signal is inflammation. A meta-analytic review of 72 studies found a fairly consistent association between sleep disturbances, including insomnia symptoms, and elevated circulating levels of IL-6 and CRP [2]. These are proteins that circulate in blood and rise during inflammatory activity, so they are practical to measure. Beyond inflammation, sleep disturbances and acute sleep loss have also been linked to a downregulation of NK cell cytotoxicity—NK cells are immune cells that kill infected or abnormal cells—and to impaired antigen-specific antibody production after vaccination [2]. That means the immune signature of poor sleep is not a single marker but a mix of inflammatory, cellular, and antibody-related changes.
A review of sleep deprivation and immune-related disease risk likewise describes alterations across immune parameters and suggests these changes could help identify at-risk individuals [1]. Separately, an integrated analysis of immune-related genes in sleep deprivation reported altered biological functions and immune cell abundance and identified key hub genes, though it did not test whether those genes predict risk [4]. So the list of candidate markers is broad, but the strength of evidence differs sharply by marker.
Why a handful of usual suspects may miss the picture
Most sleep studies that include biomarkers have relied on a small set of familiar markers such as IL-6 and CRP [2]. That approach is practical, but it likely obscures important immunologic complexity [2]. A more comprehensive study of older adults, including people with and without HIV, measured 31 biomarkers spanning eight inflammatory pathways and used data-reduction methods to group them into three clusters labeled 'gut/immune activation,' 'neurovascular,' and 'reference' [2]. The clusters differed in HIV status—a higher proportion of HIV-positive participants fell into the 'neurovascular' cluster—but they did not differ in rates of insomnia as defined by a standard symptom score, and actigraphy-based sleep measures showed only a couple of differences of low clinical relevance [2].
That null result is instructive rather than decisive. Only 82 of 465 participants met the insomnia threshold, and the clustering method accounted for just 41.5% of the variance in inflammatory activity, leaving most of the variance unexplained [2]. In plain terms, the biomarker panel captured some immune patterns but not enough to separate people by their sleep symptoms in that sample. This is a caution about how much a blood-based immune profile can currently tell us about an individual's sleep health.
How well validated are these markers for risk profiling?
Validation is uneven. The IL-6 and CRP association with sleep disturbance rests on a large meta-analytic base, which supports a consistent group-level relationship [2]. But consistency across studies is not the same as validated individual risk prediction. The comprehensive 31-biomarker study found no meaningful separation by insomnia status, suggesting that even a broad panel may not yet function as a risk-profiling tool [2].
Newer transcriptomic work moves toward validation by testing candidate biomarkers in internal and external datasets and in sleep-deprived rats, and by evaluating predictive performance [3]. A related study used machine learning to identify and validate immune-related genes in sleep deprivation and Alzheimer's disease, reporting predictive accuracy in a validation cohort [5]. These are promising steps, but they are early-stage: the markers are derived from gene-expression data and animal models, and the abstracts do not establish that they predict real-world disease risk in general populations [3][5]. The most defensible conclusion is that immune biomarkers of sleep deprivation are useful research tools and plausible risk indicators, but they are not yet validated for routine risk profiling.
Sources used in this answer
Role of sleep deprivation in immune-related disease risk and outcomes
Sleep deprivation alters immune parameters and these changes have been suggested as potentially useful for identifying individuals at risk, though the review is abstract-level evidence.
Biomarkers of sleep and insomnia—challenges and opportunities
A meta-analysis of 72 studies supports a fairly consistent association between sleep disturbances and elevated IL-6 and CRP, while sleep loss is also linked to reduced NK cell cytotoxicity and impaired antibody production; a 31-biomarker cluster study found no differences in insomnia rates across clusters.
Integrated transcriptomic identification and validation reveal key autophagy-associated biomarkers in sleep deprivation
Autophagy-associated biomarkers in sleep deprivation were identified and validated in internal and external datasets and in sleep-deprived rats, with predictive performance evaluated and associations with immune microenvironment changes explored.
Integrated Analysis of Immune-Related Genes Reveals Altered Biological Functions and Immune Cell Abundance in Sleep Deprivation
Sleep deprivation is associated with altered immune-related gene expression and immune cell abundance, with key hub genes identified, but the study does not validate these biomarkers for risk profiling or prediction.
Immune Cell Infiltration and Key Gene Identification in Alzheimer's Disease and Sleep Deprivation
Machine learning identified and validated immune-related genes in sleep deprivation and Alzheimer's disease, with predictive accuracy reported in a validation cohort, indirectly addressing biomarker validation for risk profiling.